The medical management of masseteric hypertrophy with botulinum toxin type A.
We describe the successful outpatient medical treatment of a patient with bilateral masseteric hypertrophy using botulinum toxin type A in a double-blind placebo controlled study. No significant side-effects occurred, and benefit has so far lasted for 6 months.
Moore
A P
AP
Walton Centre for Neurology and Neurosurgery, Walton Hospital, Liverpool.
Wood
G D
GD
D000328:Adult; D001905:Botulinum Toxins / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D006984:Hypertrophy / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D008297:Male; D008406:Masseter Muscle / Q000473:pathology*; D009209:Myofascial Pain Syndromes / Q000150:complications* / Q000188:drug therapy*; D010919:Placebos
D010919:Placebos; D001905:Botulinum Toxins